Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston
2
×
boston blog main
boston top stories
editas medicine
gene editing
life sciences
national blog main
agios therapeutics
allergan
base editing
branden moriarty
broad institute
cas13
clinical trials
crispr
crispr therapeutics
crispr-cas9
cynthia collins
david liu
dna
drugs
editor
editr
enzyme
feng zhang
harvard university
intellia therapeutics
john evans
katrine bosley
keith joung
leber congenital amaurosis
massachusetts general hospital
national top stories
nicole gaudelli
precise
rna
san francisco blog main
san francisco top stories
university of minnesota
What
crispr
2
×
editas
editing
gene
2
×
medicine
allergan
beam
blessing
bosley
cas
ceo
check
clinical
cusp
depart
editor
experimental
founders
gotten
harvard
humans
jump
katrine
mass
million
partner
precise
regulatory
scientists
spotlights
startup
test
therapeutics
therapy
trial
university
version
Language
Current search:
gene
×
boston
×
crispr
×
biotech
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M